Atypical Antipsychotics in the Treatment of Delusional Parasitosis

References

• Munro A: Monosymptomatic hypochondriacal psychosis. Br J Hosp Med 1980; 24:34–38
   PubMedGoogle Scholar
• Koo JYM, Gambia G: Psychodermatology: Delusions of para-sitosis and other forms of monosymptomatic hypochondriacal psychosis; general discussion and case illustrations. Dermatol Clin 1996; 14(3):429–438
   PubMed Web of Science ®Google Scholar
• Bhatia M, Jagawat T, Choudhary S: Delusional parasitosis: A clinical profile. Int J Psychiatry Ivied 2000; 30(1):83–91
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edn., text rev. Washington, DC: American Psychiatric Association; 2000:323–329
   Google Scholar
• Reilly TM, Batchelor DH: The presentation and treatment of delusional parasitosis: A dermatologic perspective. Int Clin Psychopharrnacol 1986; 1:340–353
   PubMed Web of Science ®Google Scholar
• Wykoff RF: Delusions of parasitosis: A review. Rev Infect Dis 1987; 9:433–437
   Google Scholar
• Le11 A: The Michelson lecture, delusion of parasitosis, Br J Dermatol 1983; 108: 485–499
   Google Scholar
• Trabert W: Shared psychotic disorder in delusional parasitosis. Psychopathology 1999; 32:30–34
   PubMed Web of Science ®Google Scholar
• Trabert W: 100 years of delusional parasitosis. Psychopathol-ogy 1995; 28:238–246
   PubMed Web of Science ®Google Scholar
• Berrios GE: Delusional parasitosis and physical disease. Compr Psychiatry 1985; 26:395–403
   PubMed Web of Science ®Google Scholar
• Baker PB, Cook BI, Winokur G: Delusional infestation. Psy-chiatr Clin North Am 1995; 18:345–361
   PubMedGoogle Scholar
• May WW, Terpenning MS: Delusional parasitosis in geriatric patients_ Psychosomatics 1991; 32:88–94
   Google Scholar
• Musalek M, Bach M, Passweg V. Jaeger S: The position of delusional parasitosis in psychiatric nosology and classifica-tion. Psychopathology 1990; 23:115–124
   Google Scholar
• Rasanen P, Erkonen K, Isaksson U, Koiio P, Vans R, Timonen M, Leinonen E, Isohanni M, Alanko A: Delusional parasitosis in the elderly: A review and report of six cases from northern Finland. Int Psychogeriatr 1997; 9(4):459–464
   Google Scholar
• Zomer SF, De Wit RF, Van Bonswijik JE, Naban-o G, Van Vloten WA: Delusions of parasitosis: A psychiatric disorder to be treated by dermatologists? An analysis of 33 patients. Br J Dermatol 1998; 138:1030–1032
   PubMed Web of Science ®Google Scholar
• Richelson E: Receptor pharmacology and neuroleptics: Rela-tion to clinical effects. J Clin Psychiatry 1999; 60:5–14
   PubMedGoogle Scholar
• Elmer KB, Georg RM, Peterson K: Therapeutic update: Use of risperidone for the treatment of monosymptomatic hypochon-driacal psychosis. J Am Acad Dermatol 2000; 43:683–686
   PubMed Web of Science ®Google Scholar
• Riding BE, Munro A: Pimozide in monosymptomatic delu-sional parasitosis. Lancet 1975; 1:400–401
   Google Scholar
• Monro A, Mok FL An overview of treatment in para-noia/delusional disorder. Can J Psychiatry 1995; 40:616–622
   Google Scholar
• Hanumantha K, Pradhan PV, Suvarna B: Delusional parasitosis—Study of 3 cases. J Postgrad Med 1994; 40:222–224
   PubMedGoogle Scholar
• Johnson GC, Anton RF: Pimozide in delusions of parasitosis. J Clin Psychiatry 1983; 44:233
   Google Scholar
• King BH: Hypothesis: Involvement of the serotonergic system in the clinical expression of monosymptomatic hypochondria-sis. Pharmacopsychiatry 1990; 23:85–89
   Google Scholar
• DeLeon OA, Furmaga KM, Canterbury AL, BMly LG: Risper-done in the treatment of delusions of infestation. Int J Psychi-atry Med 1997; 27:403–409
   Google Scholar
• Kitamura H: A case of somatic delusional disorder that responded to treatment with risperidone. Psychiatry Clin Neu-rosci 1997; 51(5):337
   Google Scholar
• Songer DA, Roamn B: Treatment of somatic delusional disor-der with atypical antipsychotic agents. Am J Psychiatry 1996; 153:578–579
   Google Scholar
• Heym J, Jacobs BL: Serotonergic mechanisms of hallu-cinogenic drug effects. Monogr Neural Sci 1987; 13:55–81
   Google Scholar
• Driscoll MS, Rothe MJ, Grant-Kels JM, Hale MS: Delusional parasitosis: A dermatologic, psychiatric, and pharmaco-logic approach. J Am Acad Dermatol 1993; 29:1023–1033
   PubMed Web of Science ®Google Scholar
• Peroutka SJ, Snyder SH: Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. Am I Psychiatry 1980; 137(12):1518–1522
   Google Scholar
• Bymaster FP: In vitro and in vivo biochemistry of olanzapine. J Clin Psychiatry 1997; 15(2):10–12
   Google Scholar
• McDougle CJ, Epperson CN, Pelton OH, Wasylink S, Price LH: A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibition-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57:794–801
   PubMed Web of Science ®Google Scholar
• Stein DJ, Bouwer MB, Hawkridge S, Emsley RA: Risperdone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry 1997; 58:119–122
   PubMed Web of Science ®Google Scholar